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Pleural effusions are a common reason for patients to present 
to healthcare facilities around the world. The diagnostic work-
up of exudative pleural effusions may require pleural biopsy for 
histopathological assessment in order to reach a diagnosis.[1] Closed 
blind pleural biopsy is a relatively cost-effective investigation that can 
be used to diagnose the cause of an exudative pleural effusion. The 
term ‘blind’ in this setting refers to obtaining tissue from the parietal 
pleura without directly visualising the area being sampled.
The predominant diagnoses after closed pleural biopsy in other 
studies included tuberculosis (TB) and malignancy. The prevalence 
of TB across studies varies, with rates up to 64.8%[2-6] depending on 
the population studied, rates being higher in developing countries. 
Rates of malignancy diagnosis ranged from 18.5%[6] to 100% in two 
studies performed in Scotland and India.[4,5] The most common 
malignancies diagnosed on pleural biopsy in these studies were 
adenocarcinoma (both primary lung and metastatic disease) and 
mesothelioma. Other malignancies included lymphomas, anaplastic 
carcinoma, chondrosarcoma and atypical carcinoid tumours.
There is a paucity of evidence for the use of closed blind pleural 
biopsy in the South African (SA) setting. Chris Hani Baragwanath 
Academic Hospital (CHBAH) in Soweto, Johannesburg, is the largest 
hospital in SA, and indeed in the southern hemisphere, but there 
have been no studies investigating pleural biopsies in the work-up of 
exudative pleural effusions at this hospital.
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Background. Pleural effusions are a common reason for presentation to healthcare facilities. Blind closed pleural biopsy can be a useful 
tool to diagnose their cause, especially in resource-limited settings.
Objectives. To determine the aetiology, frequency and change in profile of histopathological diagnoses made at Chris Hani Baragwanath 
Academic Hospital (CHBAH), Johannesburg, South Africa, over the period 1 January 2001 - 31 December 2015.
Methods. Pleural biopsies performed at CHBAH and analysed by histopathologists from the National Health Laboratory Service at 
the hospital over the study period were retrospectively reviewed by accessing reports from two databases (DISA and TrakCare). The 
subjects’ ages, genders, HIV status and histopathological diagnoses as well as adenosine deaminase and Ziehl-Neelsen results were 
recorded.
Results. A total of 1 013 samples were included in the study, with 780 considered adequate for assessment. The most common diagnosis 
was granulomatous inflammation (48.1%, n=375), with the most common type being necrotising granulomatous inflammation (73.6%, 
n=276). Ten percent of biopsies (n=78) showed malignancy, most commonly adenocarcinoma, with 46.2% (n=36) metastatic and 23.1% 
(n=18) primary lung adenocarcinoma. The odds of being diagnosed with malignancy showed increasing statistical significance above the 
age of 40 years: 40 - 49 years odds ratio (OR) 8.7, 95% confidence interval (CI) 1.1 - 66.9 (p=0.038); 50 - 59 years OR 12.4, 95% CI 1.6 - 95.0 
(p=0.015); ≥60 years OR 23.0, 95% CI 3.1 - 171.3 (p=0.002). HIV seropositivity was associated with lower odds of being diagnosed with 
malignancy compared with HIV-negative patients (OR 0.5, 95% CI 0.2 - 0.9; p=0.040), with greater odds of a ‘non-cancer’ diagnosis in HIV-
positive patients (including granulomatous inflammation and pleuritis (OR 2.16, 95% CI 1.03 - 4.51; p=0.040)).
Conclusions. Blind closed pleural biopsy has a role to play in the diagnosis of exudative pleural effusions in resource-limited settings, 
particularly for patients suspected to have tuberculosis (TB) or malignancy. TB remains a common cause of exudative pleural effusions. 
Patients aged >40 years presenting with an exudative pleural effusion should routinely have pleural biopsy performed. However, this study 
showed a high frequency of inadequate specimens from closed pleural biopsy. Training in the performance of this procedure to increase 
diagnostic rates is recommended.
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Objectives
To determine the aetiology, frequency and change in profile of 
histopathological diagnoses on pleural biopsy specimens at CHBAH 
over the period 1 January 2001 - 31 December 2015.
Methods
Study population and data collection
We conducted a retrospective review of closed blind pleural biopsy 
specimens taken using an Abrams needle at CHBAH over the period 
1 January 2001 - 31 December 2015. Pleural biopsy specimens taken 
during this period were submitted to the National Health Laboratory 
Service (NHLS), where they were analysed by the Department of 
Anatomical Pathology. Two databases (DISA and TrakCare) were 
accessed and the reports issued were reviewed. The following 
information was recorded: age of patient (excluded from study if 
<18 years), gender, HIV status if noted in the report, adequacy of 
specimen submitted, histopathological diagnosis made and pleural 
fluid adenosine deaminase (ADA) result, as well as Ziehl-Neelsen 
(ZN) stain result if noted on the final report.
Patient names and hospital numbers were not collected. Ethics 
approval was obtained from the University of the Witwatersrand 
Human Research Ethics Committee (ref. no. 160772).
Statistical analysis
Data were analysed using Stata version 13.1 (StataCorp, USA). 
Continuous variables were summarised using means and standard 
deviations (SDs). Tests for normality were conducted using skewness/
kurtosis testing. Significant associations in contingency tables were 
assessed using Pearson’s χ2 test, and in some cases logistic regression 
analysis was conducted. Results with p-values <0.05 were taken as 
statistically significant.
Results
A total of 1 266 pleural biopsies were reviewed from reports extrac-
ted from the NHLS records. Of these, 253 samples were excluded 
from the study: 222 samples had no patient age specified, 21 were 
specified with an age <18 years, and 10 were submitted from other 
hospitals. Repeat specimens were submitted for 23 patients: 14 of 
these samples were inadequate on first sampling, with 5 reflecting 
an inadequate sample once again on repeat sampling, 4 had a 
diagnosis of malignancy on the first sample confirmed on the second 
sample, 3 reflected pleuritis on the first sample confirmed on the 
second sample, 1 could not be processed on first sampling owing 
to a laboratory error and therefore a second sample was taken that 
confirmed pleuritis, and 1 was inconclusive on the first sample, the 
second sample reflecting primary adenocarcinoma. Samples that had 
a diagnosis made and confirmed on the second sample were included 
in the study as a single entry to avoid duplication of diagnoses; 
however, all inadequate samples and the inconclusive sample were 
included as distinct entries to allow more accurate assessment of 
inadequate sampling rates.
A total of 1 013 samples were included in the study. Of these, 
573 (56.6%) were from males and 440 (43.4%) from females. Of the 
samples, 780 (77.0%) were considered adequate and 233 (23.0%) 
were inadequate (Fig. 1). The reasons for samples being considered 
inadequate for assessment included lack of pleural tissue in the 
sample, lack of adequate pleural tissue in the sample, and samples 
damaged to the extent that adequate histological assessment could 
not be performed. Of the samples considered adequate, 43 were 
inconclusive following assessment (no specific histopathological 
diagnosis was made).
Fig. 2 shows the distribution of total samples submitted according 
to year. The largest number of samples submitted was in 2001 
(n=157) and the smallest in 2006 (n=33). The greatest proportion 
of inadequate samples was submitted in 2015 (36.7%), with a trend 
upwards in the last 5 years (Fig. 3). The majority of specimens 
submitted had no HIV status specified for the patient; 364 (35.9% 
of specimens) had HIV status specified, and of these patients 162 
(44.5%) were HIV-negative and 202 (55.5%) were HIV-positive.
The histopathological diagnoses made on pleural biopsy in this 
study were divided into four categories: granulomatous inflammation 
(necrotising, non-necrotising and undefined granulomatous 
inflammation), malignancy, nonspecific pleuritis and suppurative 
pleuritis.
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Figure 1 Study enrolment 
Total pleural biopsy 
specimens submitted
N=1 266
Specimens included 
in study
n=1 013
Adequate for assessment
n=780
Inconclusive
n=43
Excluded
n=53
Inadequate
n=233
Histopathological 
diagnosis reached
n=737
Reasons for exclusion:
• Age not specied, n=22
• Age <8 years, n=21
• Specimen submitted from 
   another hospital, n=10
Fig. 1. Study enrolment.
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Fig. 2. Sample numbers according to year.
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Fig. 3. Distribution of proportion of inadequate samples submitted by year.
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Of the adequate specimens submitted, 67 (8.6%) were found to be normal pleural tissue 
on histopathological examination. Granulomatous inflammation was found in 375 of 
the 780 specimens (48.1%) (Table 1). Of these, 276 (73.6%) demonstrated necrotising 
granulomatous inflammation, 36 (9.6%) non-necrotising granulomatous inflammation 
and 63 (3.75%) granulomatous inflammation that was not defined as either necrotising 
or non-necrotising. The mean (SD) age for the diagnosis of granulomatous inflammation 
was 44 (15) years. There was no significant association between HIV status and any type 
of granulomatous inflammation (p=0.382). Only 18 of the granulomatous specimens had 
an ADA result noted. There was no statistically significant association between any level of 
ADA and granulomatous inflammation; however, this may merely reflect the small number 
of ADA results included.
This study also recorded the ZN stain result for the histopathological specimen, if 
done. Of note, this stain was only done if the pathologist found features of granulomatous 
inflammation or, in some cases, pleuritis. However, not all specimens with features of 
granulomatous inflammation had the stain performed: 298 specimens were stained, and 
258 of these had granulomatous inflammation (126 of these were ZN-positive and 132 were 
ZN-negative). There was also no statistically significant association between a positive ZN 
result and necrotising or non-necrotising granulomatous inflammation (p=0.793).
Of the 780 specimens, 78 (10.0%) showed malignancy (Table 1). The majority 
of the malignancies were metastatic adenocarcinomas (46.2%), with primary lung 
adenocarcinoma (determined on immunohistochemical staining) second most common 
(23.1%), followed by mesothelioma (17.9%). The mean (SD) age for patients diagnosed 
with metastatic adenocarcinoma was 58 (14) years, that for primary lung adenocarcinoma 
57 (12) years and that for mesothelioma 57 (14) years. Other malignancy diagnoses were 
4 cases of adenocarcinoma of unknown primary, 3 cases of squamous cell carcinoma 
of unknown primary and 1 case of plasmablastic lymphoma. There was no statistically 
significant variance in age group affected when different malignancy diagnoses were 
compared with each other. Forty-eight percent of patients diagnosed with malignancy 
were at least 60 years of age. Logistic regression analysis showed statistically significant 
increased odds of a cancer diagnosis in the age groups 40 - 49 years (odds ratio (OR) 8.7, 
95% confidence interval (CI) 1.1 - 66.9; p=0.038), 50 - 59 years (OR 12.4, 95% CI 1.6 - 95.0; 
p=0.015) and ≥60 years (OR 23.0, 95% CI 3.1 - 171.3; p=0.002). There was no significant 
gender difference between malignancy diagnoses (p=0.450). There was also no significant 
association between HIV status and malignancy diagnosis. Logistic regression analysis 
demonstrated lower odds for being diagnosed with cancer in samples from patients who 
were HIV-positive (OR 0.5, 95% CI 0.2 - 0.9; p=0.040).
In HIV-positive patients, the odds of being diagnosed with a ‘non-cancer’ diagnosis 
(including granulomatous inflammation and pleuritis) were higher than in HIV-negative 
patients (OR 2.16, 95% CI 1.03 - 4.51; p=0.040).
The diagnosis of pleuritis was made on 217 (27.8%) of the specimens. Acute pleuritis 
accounted for 114 (52.5%) of these specimens. Chronic pleuritis was found in 82 
specimens (37.8%) and suppurative pleuritis in 21 (9.7%). There was no statistically 
significant association between the distinct types of pleuritis and HIV status.
Discussion
Pleural effusions are a common presentation in medical units around the world, and 
the work-up of a patient presenting with an exudative pleural effusion is extremely 
important for timely diagnosis and treatment. Blind closed pleural biopsy has been 
used as a relatively inexpensive means to reach a diagnosis. The majority of pleural 
biopsies at CHBAH are done by junior staff (registrars and medical officers) and not 
by specialist pulmonologists, as is the standard in more resource-rich settings. Despite 
this, 72.8% of all samples submitted led to a histopathological diagnosis, suggesting that 
pleural biopsy remains a valuable tool in our setting. However, the rate of inadequate 
samples submitted at this hospital averaged 22.6% per year, with a trend upwards in the 
years since 2010. This probably reflects inexperience and inadequate training of staff in 
correct sampling technique, as it compares poorly with rates ranging from 4.2% to 21% 
in other studies.[2,3]
Resource-related difficulties experienced at CHBAH may have impacted on sample 
numbers in some years. These difficulties included a shortage of, or damaged, Abrams 
needles. There are no clear retrospective records indicating which years these difficulties 
may have affected.Ta
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Almost half (48.1%) of all adequate samples reviewed demonstra ted 
some form of granulomatous inflammation, with the predominant 
form being necrotising granulomatous inflammation (73.6%). 
The presence of granulomas in a histological specimen cannot be 
considered diagnostic of Mycobacterium tuberculosis, and other causes 
of granulomatous inflammation should be considered. However, in 
the developing world, with a high prevalence of TB, the presence 
of granulomas should raise concerns for TB as a top differential 
diagnosis. Of the 780 adequate specimens, 134 (17.2%) showed 
positive ZN staining for acid-fast bacilli. However, not all specimens 
were stained for acid-fast bacilli, including a substantial proportion of 
specimens that showed granulomatous inflammation. This study also 
showed that there is no statistically significant association between 
ZN positivity and type of granulomatous inflammation (necrotising 
v. non-necrotising). Other studies in developing countries have 
shown a TB incidence on pleural biopsy of 32.7 - 48.9%.[7-9] Despite 
the higher prevalence of TB in HIV-positive individuals, this study 
failed to show a significant association between HIV-positive status 
and granulomatous inflammation (p=0.382). Unfortunately, owing to 
the small number of samples with HIV status and ZN result included, 
no meaningful statistics could be derived on the association between 
HIV status and ZN positivity.
Numerous studies have found an association between high ADA 
levels and TB.[9-13] The level above which an ADA result should 
be considered suggestive of TB has varied across studies, ranging 
from 30 IU/L to 70 IU/L.[10,14] In some cases in the present study, 
ADA results were provided on the report (obtained from previous 
pleurocentesis specimens submitted). However, a very low number 
of ADA results were included, and the lack of statistical significance 
in the relationship between ADA and granulomatous inflammation is 
therefore probably simply a result of low sample numbers.
Malignancies were diagnosed in 10.0% of specimens in this study, 
compared with rates of 18.5 - 100% reported in other studies. [1-10,15- 21] 
We found that the majority of malignancies diagnosed were 
adenocarcinomas, with 46.2% of all malignancies being metastatic 
adenocarcinomas and 23.1% primary lung adenocarcinomas 
(determined using immunohistochemical staining). Pereyra et al.[21] 
and Bhattacharya et al.[18] reported rates for adenocarcinoma of 40.3% 
and 65% of all malignancy diagnoses, respectively. Mesothelioma (a 
primary pleural malignancy) accounted for 17.9% of malignancies 
diagnosed in the present study. This is comparable to other studies, 
which showed rates of 9.4 - 19%.[2,7,8]
The present study supported the finding by Kalaajieh[7] that the 
rate of diagnosis of malignancy on pleural biopsy increases with 
increasing age above 50 years.[7] We showed that there are statistically 
significantly increased odds of malignancy with older age, with an 
increasing OR for every decade.
Interestingly, in the present study there was no statistically 
significant association between HIV status and granulomatous 
inflammation or malignancy. Despite only 35.9% of specimens 
having HIV status noted, logistic regression analysis demonstrated 
that the odds of being diagnosed with malignancy were higher 
in the HIV-negative subgroup of patients, and the odds of being 
diagnosed with a ‘non-cancer’ diagnosis (including pleuritis and 
granulomatous inflammation) were significantly greater in the HIV-
positive subgroup. The HIV-positive subgroup of patients was 
younger (mean age 42 years) than the HIV-negative group (mean 
age 48 years). It may be that the lower prevalence of malignancy in 
HIV-positive patients in this study simply reflects the fact that fewer 
HIV-positive than HIV-negative patients survive to the age groups 
with a higher prevalence of malignancy.
Pleuritis is a nonspecific histopathological finding. In this study, cases 
of pleuritis were subdivided into acute, chronic and suppurative, and 
of all the patients, 27.8% had some form of pleuritis. Of these, only 6 
had a positive ZN result (chronic pleuritis n=3, suppurative pleuritis 
n=2, acute pleuritis n=1).
Study limitations
The major strength of this study is the large sample size compared 
with other studies. However, our findings must be considered in 
the light of potential complications. Firstly, the study focused on a 
retrospective review of laboratory records. Patient records (kept as 
paper records at this hospital) were not utilised to add more clinical 
information such as original indication for performing the biopsy, 
other comorbidities, clinical status of the patient, or other findings 
that might have provided supportive information for the diagnosis. 
Secondly, this study relied on reports generated by the Department of 
Anatomical Pathology at the NHLS. As this was a retrospective review, 
it did not include second-party validation of the diagnosis proposed 
on the original report. Samples obtained may have been influenced 
by the experience level of the clinician performing the procedure, 
and the histopathological diagnosis may have been influenced by 
the experience level of the histopathologist assessing the specimen. 
Finally, no standardised information form was submitted when the 
original biopsy specimen was sent to the laboratory. Retrospective 
review of the reports indicated that a substantial proportion of the 
biopsy specimens submitted had information missing, such as HIV 
status and ADA result.
Conclusions
Patients with exudative pleural effusions require work-up to 
diagnose the cause. This may be elucidated by sputum microscopy, 
bronchoscopy or cytology. However, we have demonstrated that 
blind closed pleural biopsy remains a valuable tool in the work-up 
of these patients in resource-limited settings, particularly in the 
diagnosis of granulomatous disease and when there is a possibility of 
malignancy, especially in an older patient. The study also showed this 
investigation to be valuable in the diagnosis of TB in a setting of high 
HIV prevalence, especially in developing countries.
The high numbers of inadequate biopsy specimens submitted 
suggest that further training in sampling technique may improve 
diagnostic rates.
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